4//SEC Filing
Axovant Sciences Ltd. 4
Accession 0001636050-17-000031
CIK 0001636050operating
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 6:25 PM ET
Size
5.8 KB
Accession
0001636050-17-000031
Insider Transaction Report
Form 4
Mohr Stephen Frederick
General Counsel
Transactions
- Award
Employee Stock Option (Right to Buy)
2017-06-15+187,400→ 187,400 totalExercise: $20.72Exp: 2027-06-14→ Common Shares (187,400 underlying)
Footnotes (1)
- [F1]25% of the common shares underlying the option vest and become exercisable on May 30, 2018; the balance of the common shares vest in a series of 12 successive equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. Vesting is subject to acceleration in specified circumstances, including a change in control of the Issuer or the Reporting Person's termination without cause or resignation for good reason.
Documents
Issuer
Axovant Sciences Ltd.
CIK 0001636050
Entity typeoperating
Related Parties
1- filerCIK 0001636050
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 6:25 PM ET
- Size
- 5.8 KB